Concord Biotech Limited (CONCORDBIO.BO)
INR 1675.6
(-2.1%)
INR 1675.6
(-2.1%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 10.16 Billion | 8.3 Billion | 7.08 Billion | 6.04 Billion | 4.98 Billion |
| Cost of Revenue | 4.05 Billion | 1.97 Billion | 1.77 Billion | 1.2 Billion | 1.37 Billion |
| Gross Profit | 6.11 Billion | 6.33 Billion | 5.3 Billion | 4.83 Billion | 3.6 Billion |
| Operating Expenses | 1.45 Billion | 3.28 Billion | 2.94 Billion | 1.8 Billion | 1.66 Billion |
| Selling, General and Administrative Expenses | 1.23 Billion | 342 Million | 320.17 Million | 204.57 Million | 219.04 Million |
| Research and Development Expenses | 229.03 Million | 277.59 Million | 258.47 Million | 192.91 Million | 157.75 Million |
| Other Expenses | - | 62.04 Million | 9.73 Million | 11.25 Million | 2.85 Million |
| Cost and Expenses | 3.9 Billion | 5.25 Billion | 4.72 Billion | 3 Billion | 3.03 Billion |
| Operating Income | 6.26 Billion | 2.78 Billion | 2.24 Billion | 2.93 Billion | 1.83 Billion |
| Interest Expense | 31.26 Million | 45.11 Million | 54.84 Million | 6.66 Million | 6.99 Million |
| Income Tax Expense | 1.04 Billion | 819.28 Million | 625.89 Million | 778.33 Million | 445.26 Million |
| Earnings before Tax | 4.12 Billion | 3.22 Billion | 2.37 Billion | 3.12 Billion | 2.13 Billion |
| Net Income | 3.08 Billion | 2.4 Billion | 1.74 Billion | 2.34 Billion | 1.69 Billion |
| Earnings Per Share Basic | 29.45 | 22.95 | 16.72 | 22.45 | 16.17 |
| Earnings Per Share Diluted | 29.45 | 22.95 | 16.72 | 22.45 | 16.17 |
| Weighted Average Shares Outstanding | 104.61 Million | 104.61 Million | 104.61 Million | 104.61 Million | 104.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.61 Million | 104.61 Million | 104.61 Million | 104.61 Million | 104.61 Million |
| Gross Margin | 0.60 | 0.76 | 0.75 | 0.80 | 0.72 |
| EBIT Margin | 0.46 | 0.45 | 0.42 | 0.55 | 0.45 |
| Profit Margin | 0.30 | 0.29 | 0.25 | 0.39 | 0.34 |
| EBITDA | 4.65 Billion | 3.83 Billion | 2.97 Billion | 3.41 Billion | 2.35 Billion |
| Earnings Before Tax Margin | 0.62 | 0.34 | 0.32 | 0.49 | 0.37 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 2.15 Billion | 3.18 Billion | 10.16 Billion | 2.4 Billion | 2.62 Billion | 1.94 Billion |
| Cost of Revenue | 931.41 Million | 1.36 Billion | 4.05 Billion | 470.87 Million | 528.68 Million | 816.93 Million |
| Gross Profit | 1.22 Billion | 1.82 Billion | 6.11 Billion | 1.93 Billion | 2.09 Billion | 1.13 Billion |
| Operating Expenses | 545.6 Million | 618.82 Million | 2.33 Billion | 1.01 Billion | 1.03 Billion | 540.22 Million |
| Selling, General and Administrative Expenses | 545.6 Million | 618.82 Million | - | 571.09 Million | 601.22 Million | 540.22 Million |
| Research and Development Expenses | - | 229.03 Million | - | - | - | - |
| Other Expenses | 103.07 Million | 108.11 Million | 337.8 Million | 81.87 Million | 81.26 Million | 66.54 Million |
| Cost and Expenses | 1.47 Billion | 1.98 Billion | 6.38 Billion | 1.48 Billion | 1.56 Billion | 1.35 Billion |
| Operating Income | 681 Million | 1.2 Billion | 3.77 Billion | 923.91 Million | 1.05 Billion | 591.1 Million |
| Interest Expense | 2.4 Million | 4.62 Million | 25.51 Million | 4.95 Million | 8.4 Million | 7.53 Million |
| Income Tax Expense | 199.28 Million | 337.04 Million | 1.04 Billion | 255.3 Million | 286.84 Million | 165.41 Million |
| Earnings before Tax | 781.67 Million | 1.3 Billion | 4.09 Billion | 1.03 Billion | 1.09 Billion | 650.12 Million |
| Net Income | 595.93 Million | 950.16 Million | 3.08 Billion | 775.72 Million | 810.19 Million | 544.94 Million |
| Earnings Per Share Basic | 5.70 | 9.08 | - | 7.42 | 7.74 | 5.21 |
| Earnings Per Share Diluted | 5.70 | 9.08 | - | 7.42 | 7.74 | 5.21 |
| Weighted Average Shares Outstanding | 104.61 Million | 104.61 Million | 104.61 Million | 104.61 Million | 104.61 Million | 104.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.61 Million | 104.61 Million | 104.61 Million | 104.61 Million | 104.61 Million | 104.61 Million |
| Gross Margin | 0.57 | 0.57 | 0.60 | 0.80 | 0.80 | 0.58 |
| EBIT Margin | 0.38 | 0.42 | - | 0.49 | 0.47 | 0.37 |
| Profit Margin | 0.28 | 0.30 | 0.30 | 0.32 | 0.31 | 0.28 |
| EBITDA | 812.78 Million | 1.34 Billion | - | 1.17 Billion | 1.23 Billion | 721.52 Million |
| Earnings Before Tax Margin | 0.32 | 0.38 | 0.37 | 0.38 | 0.40 | 0.30 |
RAMCOSYS
CRISIL
SUPERHOUSE
PDRDF
5195
RGRNF